Drug intelligence / Profile preview

schmallenberg virus antigen

Development stage
Unknown
Lead developer
Zoetis
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular
01

Overview

Schmallenberg virus antigen is a veterinary vaccine antigen derived from Schmallenberg virus and used in inactivated viral vaccines for cattle and sheep to induce active immunity against Schmallenberg virus infection. In marketed products, the antigen is presented as whole inactivated virus, with protection mediated by antigen presentation to the host immune system and induction of neutralizing and other antiviral immune responses rather than by direct pharmacologic receptor modulation. The best-defined commercial example is the inactivated Schmallenberg virus strain BH80/11-4 antigen used in the veterinary vaccine Zulvac SBV, developed and marketed by Zoetis for prevention of Schmallenberg virus disease and reduction of viremia and transplacental infection in breeding animals.

Other names
schmallenberg virus antigeninactivated Schmallenberg virusinactivated Schmallenberg virus, strain BH80/11-4
02

Targets

GC (Vitamin D-binding protein)

Beyond the preview

Go deeper on schmallenberg virus antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on schmallenberg virus antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call